Your browser doesn't support javascript.
loading
Neuromelanin magnetic resonance imaging of the substantia nigra in LRRK2-related Parkinson's disease.
Correia Guedes, Leonor; Reimão, Sofia; Paulino, Patrícia; Nunes, Rita G; Bouça-Machado, Raquel; Abreu, Daisy; Gonçalves, Nilza; Soares, Tiago; Fabbri, Margherita; Godinho, Catarina; Pita Lobo, Patrícia; Neutel, Dulce; Quadri, Marialuisa; Coelho, Miguel; Rosa, Mario M; Campos, Jorge; Outeiro, Tiago F; Sampaio, Cristina; Bonifati, Vincenzo; Ferreira, Joaquim J.
Affiliation
  • Correia Guedes L; Department of Neurosciences and Mental Health, Neurology, Hospital de Santa Maria-CHLN, Lisbon, Portugal.
  • Reimão S; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Paulino P; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Nunes RG; Neurological Imaging Department, Hospital de Santa Maria-CHLN, Lisbon, Portugal.
  • Bouça-Machado R; Instituto de Biofísica e Engenharia Biomédica, Faculty of Science, University of Lisbon, Portugal.
  • Abreu D; Faculty of Science and Technology, Nova University of Lisbon, Campus da Caparica, Portugal.
  • Gonçalves N; Instituto de Biofísica e Engenharia Biomédica, Faculty of Science, University of Lisbon, Portugal.
  • Soares T; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Fabbri M; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Godinho C; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Pita Lobo P; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Neutel D; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Quadri M; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Coelho M; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Rosa MM; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Campos J; Department of Clinical Genetics, Erasmus MC, Rotterdam, The Netherlands.
  • Outeiro TF; Department of Neurosciences and Mental Health, Neurology, Hospital de Santa Maria-CHLN, Lisbon, Portugal.
  • Sampaio C; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
  • Bonifati V; Department of Neurosciences and Mental Health, Neurology, Hospital de Santa Maria-CHLN, Lisbon, Portugal.
  • Ferreira JJ; Clinical Pharmachology Unit, Instituto de Medicina Molecular, Lisbon, Portugal.
Mov Disord ; 32(9): 1331-1333, 2017 09.
Article de En | MEDLINE | ID: mdl-28686310

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson / Substantia nigra / Imagerie par résonance magnétique / Mélanines Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Mov Disord Sujet du journal: NEUROLOGIA Année: 2017 Type de document: Article Pays d'affiliation: Portugal

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson / Substantia nigra / Imagerie par résonance magnétique / Mélanines Limites: Aged / Aged80 / Female / Humans / Male / Middle aged Langue: En Journal: Mov Disord Sujet du journal: NEUROLOGIA Année: 2017 Type de document: Article Pays d'affiliation: Portugal